Vipul Jairath (V Jairath)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 82

Top Topics

Systematic Review

Ulcerative Colitis

Top Venues

Alimentary pharmacology & therapeutics

Inflammatory bowel diseases

Journal of Crohn's & colitis

Crohn's & colitis 360

This page only lists publications with an associated author ORCID identifier.

Publications

Cathy Lu, Ryan Rosentreter, Maxime Delisle, Mattie White, Claire E Parker, Zahra Premji, Stephanie R Wilson, Mark E Baker, Gauraang Bhatnagar, Jacob Begun, David H Bruining, Robert Bryant, Britt Christensen, Brian G Feagan, Joel G Fletcher, Vipul Jairath, John Knudsen, Torsten Kucharzik, Christian Maaser, Giovanni Maconi, Kerri L Novak, Jordi Rimola, Stuart A Taylor, Rune Wilkens, Florian Rieders, null null
Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound. Alimentary pharmacology & therapeutics (2024)
Virginia Solitano, Sudheer Kumar Vuyyuru, Achuthan Aruljothy, Maan Alkhattabi, Joshua Zou, Melanie Beaton, Jamie Gregor, Zahra Kassam, Rocio Sedano, Harry Marshall, Darryl Ramsewak, Michael Sey, Vipul Jairath
Endoscopic Skipping, Stricturing, and Penetrating Complications in Crohn's Disease on Tandem Ileo-colonoscopy and Cross-sectional Imaging: A Retrospective Cohort Study. Inflammatory bowel diseases (2024)
Léa Sequier, Bénédicte Caron, Damien Loeuille, Sailish Honap, Vipul Jairath, Patrick Netter, Silvio Danese, Jean Sibilia, Laurent Peyrin Biroulet
Systematic review: Methotrexate-A poorly understood and underused medication in inflammatory bowel disease. Alimentary pharmacology & therapeutics 60 (6) (2024)
Sudheer K Vuyyuru, Vipul Jairath
Unresolved challenges in acute severe ulcerative colitis. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology (2024)
Rupert W L Leong, Vipul Jairath, Christopher Ma
Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD. Alimentary pharmacology & therapeutics (2024)
Virginia Solitano, Heather Prins, Meagan Archer, Leonardo Guizzetti, Vipul Jairath
Toward Patient Centricity: Why Do Patients With Inflammatory Bowel Disease Participate in Pharmaceutical Clinical Trials? A Mixed-Methods Exploration of Study Participants. Crohn's & colitis 360 6 (2) (2024)
Léa Sequier, Bénédicte Caron, Damien Loeuille, Sailish Honap, Vipul Jairath, Patrick Netter, Silvio Danese, Jean Sibilia, Laurent Peyrin Biroulet
Systematic review: Methotrexate-A poorly understood and underused medication in inflammatory bowel disease. Alimentary pharmacology & therapeutics (2024)
Neeraj Narula, Hasan Hamam, Jasmine Liu, Emily Chu Lee Wong, John K Marshall, Vipul Jairath, Stephen B Hanauer, Walter Reinisch, Parambir S Dulai
Adaptive steroid tapering impedes corticosteroid-free remissions compared to forced tapering in clinical trials of ulcerative colitis. Journal of Crohn's & colitis (2024)
Cathy Lu, Ryan Rosentreter, Maxime Delisle, Mattie White, Claire E Parker, Zahra Premji, Stephanie R Wilson, Mark E Baker, Gauraang Bhatnagar, Jacob Begun, David H Bruining, Robert Bryant, Britt Christensen, Brian G Feagan, Joel G Fletcher, Vipul Jairath, John Knudsen, Torsten Kucharzik, Christian Maaser, Giovanni Maconi, Kerri L Novak, Jordi Rimola, Stuart A Taylor, Rune Wilkens, Florian Rieders, null null
Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound. Alimentary pharmacology & therapeutics 59 (8) (2024)
Jurij Hanžel, Christopher Ma, Laurent Peyrin-Biroulet, Silvio Danese, Bruce E Sands, Vipul Jairath
Differences Between the 2016 and 2022 Food and Drug Administration Guidance-Implications for Design and Interpretation of Clinical Trials in Ulcerative Colitis. Crohn's & colitis 360 6 (2) (2024)
Remo Panaccione, Christopher Ma, Vipul Jairath, Axel Dignass, Namita Joshi, Ryan Clark, Jenny Griffith, Kristina Kligys, Monika Semwal, Zachary Smith, Dominic Mitchell, Dominic Nunag, Marc Ferrante
Achievement of Endoscopic Remission After Induction Reduces Hospitalization Burden in Crohn's Disease: Findings From a Pooled Post Hoc Analysis of Risankizumab and Upadacitinib Phase III Trials. Journal of Crohn's & colitis (2024)
Virginia Solitano, Corey A Siegel, Joshua R Korzenik, Jennifer K Maratt, Douglas K Rex, Bryan Maguire, Brian Bressler, Johannes Grossmann, Rocio Sedano, John W D McDonald, Julie Remillard, Lisa M Shackelton, Guangyong Zou, Brian G Feagan, Christopher Ma, Vipul Jairath
Performance of bowel preparation quality scales in patients with Crohn's disease. Alimentary pharmacology & therapeutics (2024)
Cathy Lu, Ryan Rosentreter, Maxime Delisle, Mattie White, Claire E Parker, Zahra Premji, Stephanie R Wilson, Mark E Baker, Gauraang Bhatnagar, Jacob Begun, David H Bruining, Robert Bryant, Britt Christensen, Brian G Feagan, Joel G Fletcher, Vipul Jairath, John Knudsen, Torsten Kucharzik, Christian Maaser, Giovanni Maconi, Kerri L Novak, Jordi Rimola, Stuart A Taylor, Rune Wilkens, Florian Rieders, null null
Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound. Alimentary pharmacology & therapeutics 59 (8) (2024)
Rupert W L Leong, Vipul Jairath, Christopher Ma
Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD. Alimentary pharmacology & therapeutics 59 (12) (2024)
Sudheer Kumar Vuyyuru, Virginia Solitano, Achuthan Aruljothy, Maan Alkhattabi, Melanie Beaton, Jamie Gregor, Zahra Kassam, Harry Marshall, Darryl Ramsewak, Rocio Sedano, Michael Sey, Vipul Jairath
Prevalence of stricturing, penetrating complications and extraintestinal manifestations in inflammatory bowel disease detected on cross-sectional imaging in a tertiary care setting. United European gastroenterology journal (2024)
Maria Manuela Estevinho, Yuhong Yuan, Iago Rodriguez-Lago, Mário Sousa-Pimenta, Cláudia Camila Dias, Manuel Barreiro-de Acosta, Vipul Jairath, Fernando Magro
Efficacy and safety of probiotics in IBD: An overview of systematic reviews and updated meta-analysis of randomized controlled trials. United European gastroenterology journal (2024)
Mohammad Shehab, Amro Hassan, Fatema Alrashed, Adnan Abbas, Christopher Ma, Neeraj Narula, Vipul Jairath, Siddharth Singh, Talat Bessissow
Comparative Efficacy of Biologics and Small Molecule Therapies in Improving Patient-Reported Outcomes in Ulcerative Colitis: Systematic Review and Network Meta-Analysis. Inflammatory bowel diseases (2024)
Cathy Lu, Ryan Rosentreter, Maxime Delisle, Mattie White, Claire E Parker, Zahra Premji, Stephanie R Wilson, Mark E Baker, Gauraang Bhatnagar, Jacob Begun, David H Bruining, Robert Bryant, Britt Christensen, Brian G Feagan, Joel G Fletcher, Vipul Jairath, John Knudsen, Torsten Kucharzik, Christian Maaser, Giovanni Maconi, Kerri L Novak, Jordi Rimola, Stuart A Taylor, Rune Wilkens, Florian Rieders, null null
Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound. Alimentary pharmacology & therapeutics 59 (8) (2024)
Rupert W L Leong, Vipul Jairath, Christopher Ma
Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD. Alimentary pharmacology & therapeutics 59 (12) (2024)
Virginia Solitano, Christopher Ma, Vipul Jairath
Editorial: Advancing care in Crohn's disease-Time to standardise bowel preparation scales. Authors' reply. Alimentary pharmacology & therapeutics (2024)
Maria Jose Temido, Sailish Honap, Silvio Danese, Vipul Jairath, Fernando Magro, Francisco Portela, Laurent Peyrin-Biroulet
Nested Randomized Controlled Trials in Large Databases: An Opportunity for Inflammatory Bowel Disease? Journal of Crohn's & colitis (2024)
Christopher Ma, Brian G Feagan, Zhongya Wang, Guangyong Zou, Michelle I Smith, Lisa M Shackelton, Bruce E Sands, Remo Panaccione, Geert R D'Haens, Séverine Vermeire, Vipul Jairath
Re-evaluating Methods for Assessing Differences in Response in Ileal vs. Colonic Crohn's Disease: A Post-hoc Analysis of the FITZROY Trial. Journal of Crohn's & colitis (2024)
Sherry Rohekar, Tristan Boyd, Robert G Lambert, Melanie Beaton, Nilesh Chande, Jamie Gregor, Heather Lennox, Keith Mcintosh, Terry Ponich, Adam Rahman, Trimadhu Sharma, Michael Sey, Maria Tauqir, Vipul Jairath
Initiation of vedolizumab did not provoke new-onset spondylarthritis in patients with inflammatory bowel disease: A prospective 24-week study with imaging assessments. United European gastroenterology journal (2024)
Sudheer K Vuyyuru, Vipul Jairath
Unresolved challenges in acute severe ulcerative colitis. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 43 (1) (2024)
Virginia Solitano, Heather Prins, Meagan Archer, Leonardo Guizzetti, Vipul Jairath
Toward Patient Centricity: Why Do Patients With Inflammatory Bowel Disease Participate in Pharmaceutical Clinical Trials? A Mixed-Methods Exploration of Study Participants. Crohn's & colitis 360 6 (2) (2024)
Tommaso Lorenzo Parigi, Luca Massimino, Alfredo Carini, Roberto Gabbiadini, Peter Bertoli, Mariangela Allocca, Cristina Bezzio, Arianna Dal Buono, Ferdinando D'Amico, Federica Furfaro, Laura Loy, Alessandra Zilli, Federica Ungaro, Vipul Jairath, Laurent Peyrin-Biroulet, Alessandro Armuzzi, Silvio Danese
Prevalence, characteristics, management, and outcomes of difficult-to-treat inflammatory bowel disease. Journal of Crohn's & colitis (2024)
Jurij Hanžel, Christopher Ma, Laurent Peyrin-Biroulet, Silvio Danese, Bruce E Sands, Vipul Jairath
Differences Between the 2016 and 2022 Food and Drug Administration Guidance-Implications for Design and Interpretation of Clinical Trials in Ulcerative Colitis. Crohn's & colitis 360 6 (2) (2024)
Patrick Hamilton, Katherine Buhler, John K MacDonald, Gilaad G Kaplan, Cynthia H-T Seow, Cathy Lu, Kerri L Novak, Christopher N Andrews, Siddharth Singh, Vipul Jairath, Remo Panaccione, Christopher Ma
Meta-analysis: Placebo rates in microscopic colitis randomised trials and applications for future drug development using a historical control arm. Alimentary pharmacology & therapeutics 57 (8) (2023)
Sudheer K Vuyyuru, Tran M Nguyen, Malcolm Hogan, Tim Raine, Nurulamin M Noor, Neeraj Narula, Bram Verstockt, Brian G Feagan, Siddharth Singh, Christopher Ma, Vipul Jairath
Endoscopic and Histological Placebo Rates in Crohn's Disease Clinical Trials: A Systematic Review and Meta-analysis. Inflammatory bowel diseases (2023)
Patrick Hamilton, Katherine Buhler, John K MacDonald, Gilaad G Kaplan, Cynthia H-T Seow, Cathy Lu, Kerri L Novak, Christopher N Andrews, Siddharth Singh, Vipul Jairath, Remo Panaccione, Christopher Ma
Meta-analysis: Placebo rates in microscopic colitis randomised trials and applications for future drug development using a historical control arm. Alimentary pharmacology & therapeutics (2023)
Lotus Alphonsus, Theshani A De Silva, Christopher Ma, John K MacDonald, Jurij Hanžel, Melanie Beaton, Talat Bessissow, Maia Kayal, Rocio Sedano, Siddharth Singh, Vipul Jairath
Systematic review and meta-analysis of randomised controlled trials: Medical therapies for the treatment and prevention of pouchitis. Alimentary pharmacology & therapeutics (2023)
Patrick Hamilton, Katherine Buhler, John K MacDonald, Gilaad G Kaplan, Cynthia H-T Seow, Cathy Lu, Kerri L Novak, Christopher N Andrews, Siddharth Singh, Vipul Jairath, Remo Panaccione, Christopher Ma
Meta-analysis: Placebo rates in microscopic colitis randomised trials and applications for future drug development using a historical control arm. Alimentary pharmacology & therapeutics 57 (8) (2023)
Jurij Hanžel, Christopher Ma, Theshani Amalka De Silva, Lotus Alphonsus, Leonardo Guizzetti, Eileen Crowley, Siddharth Singh, Vipul Jairath
Approval Timelines for Advanced Therapeutics in Inflammatory Bowel Disease: A Comparison Between the European Medicines Agency and the Food and Drug Administration. Inflammatory bowel diseases (2023)
Achuthan Aruljothy, Siddharth Singh, Neeraj Narula, Gordon William Moran, Sudheer K Vuyyuru, Malcolm Hogan, Alexa Zayadi, John K MacDonald, Benedicte Caron, Silvio Danese, Laurent Peyrin Biroulet, Christopher Ma, Vipul Jairath
Systematic review with meta-analysis: Medical therapies for treatment of ulcerative proctitis. Alimentary pharmacology & therapeutics (2023)
Sudheer K Vuyyuru, Christopher Ma, Tanmay Sharma, Tran M Nguyen, Talat Bessissow, Neeraj Narula, Siddharth Singh, Florian Rieder, Vipul Jairath
Characteristics of Interventional Trials for Patients Living With Intestinal Stoma Registered in ClinicalTrials.gov With a Focus on Inflammatory Bowel Disease. Inflammatory bowel diseases (2023)
Sudheer K Vuyyuru, Christopher Ma, Tanmay Sharma, Tran M Nguyen, Talat Bessissow, Neeraj Narula, Siddharth Singh, Florian Rieder, Vipul Jairath
Characteristics of Interventional Trials for Patients Living With Intestinal Stoma Registered in ClinicalTrials.gov With a Focus on Inflammatory Bowel Disease. Inflammatory bowel diseases (2023)
Sudheer K Vuyyuru, Christopher Ma, Tanmay Sharma, Tran M Nguyen, Talat Bessissow, Neeraj Narula, Siddharth Singh, Florian Rieder, Vipul Jairath
Characteristics of Interventional Trials for Patients Living With Intestinal Stoma Registered in ClinicalTrials.gov With a Focus on Inflammatory Bowel Disease. Inflammatory bowel diseases (2023)
Mohammad Shehab, Sahad Al Akram, Amro Hassan, Fatema Alrashed, Vipul Jairath, Talat Bessissow
Histological Disease Activity as Predictor of Clinical Relapse, Hospitalization, and Surgery in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis. Inflammatory bowel diseases (2023)
Rocio Sedano, Leonardo Guizzetti, Cassandra McDonald, Melanie Beaton, Nilesh Chande, Jamie Gregor, Michael Sey, Aze Wilson, Vipul Jairath
Clinical, Endoscopic, and Radiological Effectiveness of Ustekinumab in Bio-naïve Versus Bio-experienced Patients With Crohn's Disease: Real-world Experience From a Large Canadian Center. Inflammatory bowel diseases (2022)
Rocio Sedano, Malcolm Hogan, Cassandra McDonald, Tina Aswani-Omprakash, Christopher Ma, Vipul Jairath
Underrepresentation of Minorities and Lack of Race Reporting in Ulcerative Colitis Drug Development Clinical Trials. Inflammatory bowel diseases 28 (8) (2022)
Rocio Sedano, Malcolm Hogan, Guangyong Zou, Neeraj Narula, Siddharth Singh, Christopher Ma, Brian G Feagan, Vipul Jairath
Comparison of the Relative Sensitivity of Clinical, Endoscopic, and Histologic Remission for Detection of Treatment Efficacy in Ulcerative Colitis Trials. Inflammatory bowel diseases (2022)
Sudheer K Vuyyuru, Mayur Brahmania, Juan Pablo Arab, Vipul Jairath
Biologics Are Effective in the Management of Inflammatory Bowel Disease Following Liver Transplantation in Combination With Antirejection Therapy. Inflammatory bowel diseases 28 (12) (2022)
Paolo Angelo Cortesi, Gionata Fiorino, Laurent Peyrin Biroulet, Lorenzo Giovanni Mantovani, Vipul Jairath, Kristine Paridaens, Fredrik L Andersson, Silvio Danese
Non-invasive monitoring and treat-to-target approach are cost-effective in patients with mild-moderate ulcerative colitis. Alimentary pharmacology & therapeutics (2022)
Jurij Hanžel, Rocio Sedano, Jenny Jeyarajah, Guangyong Zou, Stefanie C McFarlane, Christopher Ma, Vipul Jairath
Similar Clinical Improvement Rates Among Biologic Drug Classes in Crohn's Disease: Systematic Review and Meta-Regression. Inflammatory bowel diseases 28 (9) (2022)
Rocio Sedano, Christopher Ma, Rish K Pai, Geert D' Haens, Leonardo Guizzetti, Lisa M Shackelton, Julie Remillard, Paolo Gionchetti, Ilyssa O Gordon, Stefan Holubar, Maia Kayal, Gregory Y Lauwers, Reetesh K Pai, Darrell S Pardi, Mark A Samaan, David F Schaeffer, Bo Shen, Mark S Silverberg, Brian G Feagan, William J Sandborn, Vipul Jairath
An expert consensus to standardise clinical, endoscopic and histologic items and inclusion and outcome criteria for evaluation of pouchitis disease activity in clinical trials. Alimentary pharmacology & therapeutics 53 (10) (2021)
Sushrut Jangi, Hyuk Yoon, Parambir S Dulai, Mark Valasek, Brigid Boland, Vipul Jairath, Brian G Feagan, William J Sandborn, Siddharth Singh
Letter: the combination of histologic remission and Mayo endoscopic score 1 as a suitable therapeutic target in ulcerative colitis-authors' reply. Alimentary pharmacology & therapeutics 53 (8) (2021)
Ian Roberts, Haleema Shakur-Still, Adefemi Afolabi, Adegboyega Akere, Monica Arribas, Emma Austin, Kiran Bal, Nuha Bazeer, Danielle Beaumont, Amy Brenner, Laura Carrington, Rizwana Chaudhri, Timothy John Coats, Ian Gilmore, Kenneth Halligan, Irshad Hussain, Vipul Jairath, Kiran Javaid, Aasia Kayani, J P Luyendyk, Raoul Mansukhani, Alec Miners, Muttiullah Mutti, Muhammad Arif Nadeem, Richard C G Pollok, Danielle Prowse, Jonathan Simmons, Simon J Stanworth, Andrew M Veitch, Jack Williams
A high-dose 24-hour tranexamic acid infusion for the treatment of significant gastrointestinal bleeding: HALT-IT RCT. Health technology assessment (Winchester, England) 25 (58) (2021)
Rocio Sedano, Christopher Ma, Vipul Jairath
Editorial: standardising inclusion and outcome criteria for pouchitis-a fragile consensus perhaps but a first step in the right direction. Authors' reply. Alimentary pharmacology & therapeutics 53 (10) (2021)
Anas Hussameddin, Rocio Sedano, Darryl Ramsewak, David Driman, Vipul Jairath
Vedolizumab-Induced Endoscopic and Histologic Improvement in Gastric Menetrier's Disease in a Patient With Ulcerative Colitis. Inflammatory bowel diseases 27 (11) (2021)
Thomas M Goodsall, Vipul Jairath, Robert V Bryant, Christopher Ma
Editorial: use of intestinal ultrasound in the scoring of Crohn's disease activity in clinical trials - is it ready for prime time yet? Authors' reply. Alimentary pharmacology & therapeutics 53 (8) (2021)
Christopher Ma, John K MacDonald, Tran M Nguyen, Joshua Chang, Niels Vande Casteele, Brian G Feagan, Vipul Jairath
Systematic review: disease activity indices for immune checkpoint inhibitor-associated enterocolitis. Alimentary pharmacology & therapeutics (2021)
Vipul Jairath, Leonardo Guizzetti, K Adam Baker, Lee Anne Williamson, Rocio Sedano, Hershell Thompson, Christopher Ma
Impact of COVID-19 on Inflammatory Bowel Disease Clinical Trial Recruitment: A Global Survey of Principal Investigators. Inflammatory bowel diseases 27 (8) (2021)
Ahmed Almradi, Christopher Ma, Geert R D'Haens, William J Sandborn, Claire E Parker, Leonardo Guizzetti, Paula Borralho Nunes, Gert De Hertogh, Roger M Feakins, Reena Khanna, Gregory Y Lauwers, Aart Mookhoek, Reetesh K Pai, Laurent Peyrin Biroulet, Robert Riddell, Christophe Rosty, David F Schaeffer, Mark A Valasek, Siddharth Singh, Eileen Crowley, Brian G Feagan, Vipul Jairath, Rish K Pai
An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trials. Alimentary pharmacology & therapeutics 53 (7) (2021)
Sushrut Jangi, Hyuk Yoon, Parambir S Dulai, Mark Valasek, Brigid S Boland, Vipul Jairath, Brian G Feagan, William J Sandborn, Siddharth Singh
Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing. Alimentary pharmacology & therapeutics 52 (6) (2020)
Omar Kherad, Vipul Jairath
Editorial: blood transfusion for lower gastrointestinal bleeding-authors' reply. Alimentary pharmacology & therapeutics 49 (7) (2020)
Rish K Pai, Brian G Feagan, Claire E Parker, Vipul Jairath, Stephen Caldwell
Editorial: evolving histological assessment of NASH. Authors' reply. Alimentary pharmacology & therapeutics 50 (11-12) (2020)
Alexandra Istl, Mei L Yang, Katherine A Fleshner, Claire E Parker, Leonardo Guizzetti, Siddharth Singh, Vipul Jairath
Letter: pre-operative anti-TNF therapy in Crohn's disease is not associated with increased complications following elective surgery. Alimentary pharmacology & therapeutics 50 (4) (2020)
Siddharth Singh, Vipul Jairath
Letter: immunogenicity of anti-TNF in elderly IBD patients-authors' reply. Alimentary pharmacology & therapeutics 50 (3) (2020)
Niels Vande Casteele, Vipul Jairath
Editorial: assessing histological disease activity in Crohn's disease-a call for standardisation of mucosal biopsy location. Authors' reply. Alimentary pharmacology & therapeutics 50 (1) (2020)
Parambir S Dulai, Vipul Jairath, Reena Khanna, Christopher Ma, Kelly P McCarrier, Mona L Martin, Claire E Parker, Joan Morris, Brian G Feagan, William J Sandborn
Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis. Alimentary pharmacology & therapeutics 51 (11) (2020)
Siddharth Singh, Vipul Jairath, Stitt Lw, Zou G, Khanna R, Dulai Ps, Sandborn Wj, Feagan Bg
Editorial: combination immunosuppressive therapy to treat Crohn's disease - ready for all age groups? Authors' reply. Alimentary pharmacology & therapeutics 49 (12) (2020)
Rish K Pai, Vipul Jairath, Brian G Feagan
Editorial: histologic normalisation in ulcerative colitis. Alimentary pharmacology & therapeutics 51 (3) (2020)
Siddharth Singh, Jihoon Kim, Wenhong Zhu, Parambir S Dulai, William J Sandborn, Vipul Jairath
No benefit of continuing vs stopping 5-aminosalicylates in patients with ulcerative colitis escalated to anti-metabolite therapy. Alimentary pharmacology & therapeutics 52 (3) (2020)
Robert Battat, Niels Vande Casteele, Rish K Pai, Zhongya Wang, Guangyong Zou, John W D McDonald, Marjolijn Duijvestein, Jenny Jeyarajah, Claire E Parker, Tanja Van Viegen, Sigrid A Nelson, Brigid S Boland, Siddharth Singh, Parambir S Dulai, Mark A Valasek, Brian G Feagan, Vipul Jairath, William J Sandborn
Evaluating the optimum number of biopsies to assess histological inflammation in ulcerative colitis: a retrospective cohort study. Alimentary pharmacology & therapeutics 52 (10) (2020)
Vipul Jairath, C Ma, Brian G Feagan
Editorial: aminosalicylates in Crohn's disease-prevalence, risks, costs and time to reassess? Authors' reply. Alimentary pharmacology & therapeutics 48 (4) (2019)
Adam Rahman, Vipul Jairath, Brian G Feagan, Reena Khanna, Salimah Z Shariff, Britney N Allen, Krista Bray Jenkyn, Christopher Vinden, Jenny Jeyarajah, Mahmoud Mosli, Eric Benchimol
Declining hospitalisation and surgical intervention rates in patients with Crohn's disease: a population-based cohort. Alimentary pharmacology & therapeutics 50 (10) (2019)
Christopher Ma, Jeffrey K Lee, Anish R Mitra, Anouar Teriaky, Daksh Choudhary, Tran M Nguyen, Niels Vande Casteele, Reena Khanna, Remo Panaccione, Brian G Feagan, Vipul Jairath
Systematic review with meta-analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel disease. Alimentary pharmacology & therapeutics 50 (1) (2019)
Siddharth Singh, Larry W Stitt, Guangyong Zou, Reena Khanna, Parambir S Dulai, William J Sandborn, Brian G Feagan, Vipul Jairath
Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT. Alimentary pharmacology & therapeutics 49 (9) (2019)
Michael Sai Lai Sey, Seid B Mohammed, Mayur Brahmania, Siddharth Singh, Brennan C Kahan, Vipul Jairath
Comparative outcomes in patients with ulcer- vs non-ulcer-related acute upper gastrointestinal bleeding in the United Kingdom: a nationwide cohort of 4474 patients. Alimentary pharmacology & therapeutics 49 (5) (2019)
R K Pai, A J Bredenoord, Brian G Feagan, Vipul Jairath
Editorial: validating reliability of the eosinophilic oesophagitis histological scoring system (EOE-HSS)-an important first step. Authors' reply. Alimentary pharmacology & therapeutics 47 (12) (2019)
Vipul Jairath, Suvi R K Hokkanen, Leonardo Guizzetti, Naomi Boxall, Sarah Campbell-Hill, Haridarshan Patel
No increased risk of nephrotoxicity associated with 5-aminosalicylic acid in IBD: a population-based cohort and nested case-control study. Alimentary pharmacology & therapeutics 50 (4) (2019)
Omar Kherad, Sophie Restellini, Myriam Martel, Michael Sai Lai Sey, Michael F Murphy, Kathryn Oakland, Alan N Barkun, Vipul Jairath
Outcomes following restrictive or liberal red blood cell transfusion in patients with lower gastrointestinal bleeding. Alimentary pharmacology & therapeutics 49 (7) (2019)
Rish K Pai, David E Kleiner, John Hart, Oyedele A Adeyi, Andrew D Clouston, Cynthia A Behling, Dhanpat Jain, Sanjay Kakar, Mayur Brahmania, Lawrence Burgart, Kenneth P Batts, Mark A Valasek, Michael S Torbenson, Maha Guindi, Hanlin L Wang, Veeral Ajmera, Leon A Adams, Claire E Parker, Brian G Feagan, Stephen Caldwell, Vipul Jairath
Standardising the interpretation of liver biopsies in non-alcoholic fatty liver disease clinical trials. Alimentary pharmacology & therapeutics 50 (10) (2019)
M J Warners, C A Ambarus, A J Bredenoord, J Verheij, G Y Lauwers, J C Walsh, David A Katzka, S Nelson, T van Viegen, G T Furuta, S K Gupta, L Stitt, G Zou, C E Parker, Lisa M Shackelton, G R D Haens, W J Sandborn, E S Dellon, Brian G Feagan, M H Collins, Vipul Jairath, Rish K Pai
Reliability of histologic assessment in patients with eosinophilic oesophagitis. Alimentary pharmacology & therapeutics 47 (7) (2018)
Christopher Ma, S J Dutton, L E Cipriano, Siddharth Singh, C E Parker, T M Nguyen, L Guizzetti, J C Gregor, N Chande, P Hindryckx, Brian G Feagan, Vipul Jairath
Systematic review with meta-analysis: prevalence, risk factors and costs of aminosalicylate use in Crohn's disease. Alimentary pharmacology & therapeutics 48 (2) (2018)
Christopher Ma, Leonardo Guizzetti, Lauren E Cipriano, Claire E Parker, Tran M Nguyen, James C Gregor, Nilesh Chande, Brian G Feagan, Vipul Jairath
Systematic review with meta-analysis: high prevalence and cost of continued aminosalicylate use in patients with ulcerative colitis escalated to immunosuppressive and biological therapies. Alimentary pharmacology & therapeutics 49 (4) (2018)
M A Samaan, C A J Puylaert, B G Levesque, G Y Zou, L Stitt, S A Taylor, Lisa M Shackelton, M K Vandervoort, R Khanna, C Santillan, J Rimola, P Hindryckx, C Y Nio, W J Sandborn, G D'Haens, Brian G Feagan, Vipul Jairath, J Stoker
The development of a magnetic resonance imaging index for fistulising Crohn's disease. Alimentary pharmacology & therapeutics 46 (5) (2017)
Samuel Paul Costello, W Soo, R V Bryant, Vipul Jairath, A L Hart, J M Andrews
Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Alimentary pharmacology & therapeutics 46 (3) (2017)
Vipul Jairath, N Vande Casteele, P Hindryckx
Letter: dose optimising infliximab in acute severe ulcerative colitis - authors' reply. Alimentary pharmacology & therapeutics 45 (8) (2017)
Vipul Jairath, Brian G Feagan
Editorial: the impact of the placebo effect in Crohn's disease - author's reply. Alimentary pharmacology & therapeutics 45 (11) (2017)
Samuel Paul Costello, W Soo, R V Bryant, Vipul Jairath, A L Hart, J M Andrews
Editorial: faecal microbiota transplantation for ulcerative colitis-not quite there yet? Authors' reply. Alimentary pharmacology & therapeutics 46 (6) (2017)
William A Bye, Vipul Jairath, Simon P L Travis
Editorial: gut selective immunosuppression-is it a double edged sword? Authors' reply. Alimentary pharmacology & therapeutics 46 (3) (2017)